Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 1
2011 1
2014 1
2016 2
2017 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Novel PEFC Application for Deuterium Isotope Separation.
Matsushima H, Ogawa R, Shibuya S, Ueda M. Matsushima H, et al. Among authors: Ueda M. Materials (Basel). 2017 Mar 16;10(3):303. doi: 10.3390/ma10030303. Materials (Basel). 2017. PMID: 28772661 Free PMC article.
[Pharmacogenetics/pharmacogenomics in psychiatry].
Ueda M, Ishiguro S, Watanabe T, Saeki Y, Shimoda K. Ueda M, et al. Nihon Rinsho. 2010 Jan;68(1):155-62. Nihon Rinsho. 2010. PMID: 20077810 Review. Japanese.
Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder.
Watanabe T, Ueda M, Ishiguro S, Hayashi Y, Aoki A, Shinozaki M, Kato K, Akiyama K, Shimoda K. Watanabe T, et al. Among authors: Ueda M. Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):382-390. doi: 10.9758/cpn.2017.15.4.382. Clin Psychopharmacol Neurosci. 2017. PMID: 29073750 Free PMC article.
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.
Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K. Aoki A, et al. Among authors: Ueda M. Neuropsychiatr Dis Treat. 2014 Sep 18;10:1793-8. doi: 10.2147/NDT.S68670. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25258536 Free PMC article.
Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.
Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N. Nishimura M, et al. Among authors: Ueda M. Pharmacogenet Genomics. 2016 Sep;26(9):403-13. doi: 10.1097/FPC.0000000000000228. Pharmacogenet Genomics. 2016. PMID: 27187662
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
Ishiguro S, Watanabe T, Ueda M, Saeki Y, Hayashi Y, Akiyama K, Saito A, Kato K, Inoue Y, Shimoda K. Ishiguro S, et al. Among authors: Ueda M. Eur J Clin Pharmacol. 2011 Dec;67(12):1213-21. doi: 10.1007/s00228-011-1073-9. Epub 2011 Jun 19. Eur J Clin Pharmacol. 2011. PMID: 21688171
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.
Saeki Y, Watanabe T, Ueda M, Saito A, Akiyama K, Inoue Y, Hirokane G, Morita S, Yamada N, Shimoda K. Saeki Y, et al. Among authors: Ueda M. Eur J Clin Pharmacol. 2009 Jul;65(7):685-91. doi: 10.1007/s00228-009-0633-8. Epub 2009 Mar 4. Eur J Clin Pharmacol. 2009. PMID: 19259652
11 results
Jump to page
Feedback